Clinical Trials Logo

Clinical Trial Summary

The aim of this clinical trial is to evaluate the efficacy and safety of two intravenous administrations of ilofotase alfa in patients at risk for renal damage following open heart surgery.


Clinical Trial Description

This is a Phase 2, multi-center, randomized, double-blind, placebo-controlled, 2-arm parallel group design trial in patients at risk for renal damage following open heart surgery. After screening and baseline assessments, eligible patients will be randomized 1:1 to either 2 doses of 128 mg ilofotase alfa, or 2 doses of placebo control. Randomization will be stratified by baseline eGFR and type of surgery. The patient will be treated with the investigational product (ilofotase alfa or placebo) at the same day before and after the surgery (Day 1). Follow-up clinic visits will be performed daily up to Day 5 for efficacy, safety, and pharmocokinetics assessments. A safety follow-up can be performed by telephone at Day 28. At Day 61, an end of trial visit will be done at site for efficacy, safety, and anti-drug antibodies assessments. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06168799
Study type Interventional
Source AM-Pharma
Contact Hof
Phone +31302289222
Email CSA-RD.phase2@am-pharma.com
Status Recruiting
Phase Phase 2
Start date December 19, 2023
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT06203184 - The Effect of Video Game-Based Exercises After Open Heart Surgery N/A
Not yet recruiting NCT03806413 - Post-surgical Delirium in Patients Undergoing Open Heart Surgery.
Recruiting NCT04670367 - The Effects of Baduanjin Exercise on Meridian Energy and Heart Rate Variability in Patients Undergoing Cardiac Sugery N/A
Terminated NCT04506762 - Benefit of Peri-operative Bilateral ESP Catheters for Enhanced Recovery for Cardiac Surgery (ERCS) N/A
Completed NCT05316207 - Tele-Nursing Follow-Up After Open Heart Surgery N/A
Completed NCT06436872 - The Effect of Informing the Relatives of Patients Undergoing Open Heart Surgery N/A
Recruiting NCT05441358 - Assessment of Platelet Function in Patients Undergoing Open Heart Surgery
Not yet recruiting NCT05715060 - Sternal Closure in Children After Cardiac Surgery N/A
Not yet recruiting NCT05222256 - Comparison Between Levosimendan and Adrenaline in CABG Patients N/A
Completed NCT03105089 - Effect of Cardiac Preconditioning Upon the Inotrope Score N/A
Completed NCT05149235 - Gaming Technology and Cardiac Rehabilitation N/A
Completed NCT03106818 - Postoperative Pain Alleviation in Open Heart Surgery N/A
Completed NCT04486690 - Neuroprotection During Open Heart Surgery Phase 3
Completed NCT01069562 - Closed Loop Isoflurane Administration With Bispectral Index in Open Heart Surgery N/A
Recruiting NCT05522712 - Acapella Versus Incentive Spirometer on Cardiopulmonary Fitness After Heart Valve Surgery. N/A
Completed NCT04213040 - Procalcitonin and Postoperative Outcome After Open-heart Surgery
Completed NCT06165861 - The Effect of Using Virtual Reality Glasses on Surgical Fear and Anxiety N/A
Active, not recruiting NCT03955536 - Comparison of the Effects of Different Physiotherapy and Rehabilitation Methods on Open Heart Surgery N/A
Recruiting NCT03799965 - The Effect of Advanced Improvement Program (ERAS) on Postoperative Outcomes in Patients Undergoing Open Heart Surgery N/A
Completed NCT05932368 - Early Evaluation After Cardiac Surgery